Skip to main content
logo
Vaxil Bio Ltd. (TSXV:VXL)
Canada flag Canada · Delayed Price · Currency is CAD
0.1600
0.00 (0.00%)
At close: Aug 18, 2026

Vaxil Bio Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1113310
Market Cap Growth
45.42%-57.83%-60.00%25.00%-73.33%-70.43%
Enterprise Value
001218
Last Close Price
0.160.140.501.251.003.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1.041.11----
PB Ratio
0.510.421.913.842.416.04
P/TBV Ratio
0.510.421.913.842.416.04

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.42-0.49-0.63-1.05-1.33-1.32
Net Debt / EBITDA Ratio
---3.722.602.32
Quick Ratio
16.92134.8026.7711.263.783.89
Current Ratio
16.92137.0043.1211.483.813.90
Return on Equity (ROE)
50.89%50.07%-16.18%-25.06%-41.19%-78.75%
Return on Assets (ROA)
-13.52%-10.64%-10.82%-12.61%-19.08%-31.23%
Return on Capital Employed (ROCE)
-17.00%-13.10%-20.70%-28.50%-51.40%-58.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
76.09%90.36%-13.00%-7.42%-21.32%-9.60%
Buyback Yield / Dilution
-14.84%-3.48%---0.64%-33.78%